Rose M. Fields

649 total citations
15 papers, 555 citations indexed

About

Rose M. Fields is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rose M. Fields has authored 15 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rose M. Fields's work include Metabolism, Diabetes, and Cancer (6 papers), Pancreatic function and diabetes (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Rose M. Fields is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Pancreatic function and diabetes (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Rose M. Fields collaborates with scholars based in United States and Poland. Rose M. Fields's co-authors include Barbara V. Howard, W F Beltz, Marja‐Riitta Taskinen, Scott M. Grundy, Peter H. Bennett, I Harper, David M. Mott, B. V. Howard, Gustav Schonfeld and J Sommercorn and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and The Journal of Infectious Diseases.

In The Last Decade

Rose M. Fields

15 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rose M. Fields United States 11 258 231 194 112 90 15 555
Stuart W. Weidman United States 11 272 1.1× 74 0.3× 225 1.2× 123 1.1× 63 0.7× 20 559
John W. Carpenter United States 12 214 0.8× 298 1.3× 141 0.7× 126 1.1× 101 1.1× 23 678
David Marais South Africa 11 165 0.6× 129 0.6× 155 0.8× 52 0.5× 249 2.8× 16 534
R. S. Lees United States 7 163 0.6× 96 0.4× 166 0.9× 66 0.6× 41 0.5× 10 397
Ghada Abdel‐Fattah United States 9 83 0.3× 141 0.6× 192 1.0× 51 0.5× 93 1.0× 10 500
Jeffrey Rhyne United States 14 155 0.6× 171 0.7× 203 1.0× 107 1.0× 67 0.7× 16 487
William L. Blake United States 13 83 0.3× 252 1.1× 236 1.2× 110 1.0× 80 0.9× 19 619
Camilla Skoglund-Andersson Sweden 7 174 0.7× 83 0.4× 127 0.7× 60 0.5× 62 0.7× 8 367
Rocco Gulli United States 10 112 0.4× 156 0.7× 67 0.3× 156 1.4× 140 1.6× 13 509
Yoshiyasu Shinohara Japan 11 163 0.6× 217 0.9× 84 0.4× 139 1.2× 451 5.0× 18 665

Countries citing papers authored by Rose M. Fields

Since Specialization
Citations

This map shows the geographic impact of Rose M. Fields's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose M. Fields with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose M. Fields more than expected).

Fields of papers citing papers by Rose M. Fields

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose M. Fields. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose M. Fields. The network helps show where Rose M. Fields may publish in the future.

Co-authorship network of co-authors of Rose M. Fields

This figure shows the co-authorship network connecting the top 25 collaborators of Rose M. Fields. A scholar is included among the top collaborators of Rose M. Fields based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rose M. Fields. Rose M. Fields is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sommercorn, J, Rose M. Fields, Itamar Raz, & Ryo Maeda. (1993). Abnormal regulation of ribosomal protein S6 kinase by insulin in skeletal muscle of insulin-resistant humans.. Journal of Clinical Investigation. 91(2). 509–513. 8 indexed citations
2.
Hara, Hitoshi, L. Patti, Giacomo Ruotolo, et al.. (1992). Increased receptor binding of low-density lipoprotein from individuals consuming a high-carbohydrate, low-saturated-fat diet. Metabolism. 41(11). 1154–1160. 9 indexed citations
3.
Fields, Rose M., B. L. Grégoire Nyomba, Itamar Raz, et al.. (1991). Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans. Diabetes. 40(7). 939–942. 90 indexed citations
4.
Howard, Barbara V., William G.H. Abbott, W F Beltz, et al.. (1987). Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Metabolism. 36(9). 870–877. 63 indexed citations
5.
Taskinen, Marja‐Riitta, W F Beltz, I Harper, et al.. (1986). Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes. 35(11). 1268–1277. 62 indexed citations
6.
Taskinen, Marja‐Riitta, W F Beltz, I Harper, et al.. (1986). Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy. Diabetes. 35(11). 1268–1277. 130 indexed citations
7.
Howard, Barbara V., David M. Mott, Hideki Hidaka, et al.. (1981). Cell culture studies of a patient with congenital lipoatrophic diabetes—Normal insulin binding with alterations in intracellular glucose metabolism and insulin action. Metabolism. 30(9). 845–852. 16 indexed citations
8.
Howard, Barbara V., Hideki Hidaka, Fukashi Ishibashi, Rose M. Fields, & Peter H. Bennett. (1981). Type II Diabetes and Insulin Resistance: Evidence for Lack of Inherent Cellular Defects in Insulin Sensitivity. Diabetes. 30(7). 562–567. 11 indexed citations
9.
Ishibashi, Fukashi, Hisashi Hidaka, Rose M. Fields, B. V. Howard, & P. H. Bennett. (1981). Alloxan action on glucose metabolism in cultured fibroblasts. I. Stimulation and inhibition of glucose utilization. American Journal of Physiology-Endocrinology and Metabolism. 240(6). E640–E644. 2 indexed citations
10.
Hidaka, Hideki, Barbara V. Howard, Rose M. Fields, et al.. (1980). Insulin Stimulation of Glycogen Synthase in Cultured Human Diploid Fibroblasts. Diabetes. 29(10). 806–810. 19 indexed citations
11.
Hidaka, Hideki, Barbara V. Howard, Rose M. Fields, et al.. (1980). Insulin stimulation of glycogen synthase in cultured human diploid fibroblasts. Diabetes. 29(10). 806–810. 10 indexed citations
12.
Howard, Barbara V., Rose M. Fields, David M. Mott, et al.. (1980). Diabetes and Cell Growth—Lack of Differences in Growth Characteristics of Fibroblasts from Diabetic and Nondiabetic Pima Indians. Diabetes. 29(2). 119–124. 23 indexed citations
13.
Howard, Barbara V., David M. Mott, Rose M. Fields, & Peter H. Bennett. (1979). Insulin stimulation of glucose entry in cultured human fibroblasts. Journal of Cellular Physiology. 101(1). 129–138. 63 indexed citations
14.
Maynard, J. E., Daniel W. Bradley, Cecil L. Hornbeck, et al.. (1976). Preliminary Serologic Studies of Antibody to Hepatitis A Virus in Populations in the United States. The Journal of Infectious Diseases. 134(5). 528–530. 48 indexed citations
15.
Murphy, Bert L., et al.. (1971). Occurrence of a Carrier State for Herpesvirus tamarinus in Marmosets. Applied Microbiology. 21(1). 50–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026